Navigation Links
Quest Diagnostics Reports Strong Performance in Third Quarter 2009
Date:11/4/2009

MADISON, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the third quarter ended September 30, 2009, income from continuing operations rose to $192 million, or $1.02 per diluted share, from $160 million, or $0.81 per diluted share, for the third quarter of 2008. In 2008, third quarter results were reduced by a $0.03 per share charge associated with the write-down of an equity investment, and a $0.02 per share impact associated with hurricanes.

Third quarter revenues increased 3.9% to $1.9 billion compared to the prior year. Clinical testing revenues increased by 4.3% compared to the prior year. Revenue per requisition increased 4.3%. Underlying volume in clinical testing, measured by the number of requisitions, continued to grow in the quarter. Reported testing volume was unchanged from the prior year and reflected a 23% decline in drugs-of-abuse testing volume, which is sensitive to hiring trends, and which reduced the company's consolidated volume by 1.7%. In the third quarter of 2008, consolidated revenues and volume were reduced by approximately half a percent as a result of the impact of hurricanes.

"Quest Diagnostics' strong financial performance continues to be driven by increased demand in testing for cancer, sexually transmitted diseases, allergies and Vitamin D levels. Based on our strong performance, we are raising earnings guidance for the full year," said Surya N. Mohapatra, Ph.D., Chairman and Chief Executive Officer. "Our continued focus on innovation is driving growth today and positioning Quest Diagnostics well for the future. We recently introduced the first commercial test for the H1N1 flu virus authorized by the FDA for emergency use, and launched a saliva-based genetic test th
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology news :

1. Quest Diagnostics Reports Strong Performance in Third Quarter 2009
2. Chimpanzees help each other on request but not voluntarily
3. Critical Zone Observatory seeks to answer climate change questions
4. Department of Energy supports carbon sequestration research, University of Miami receives $1.7 million
5. Aurora B answers an XIST-ential question
6. Carnegie Mellon team makes sequestration recommendations
7. International conference on CO2 sequestration processes
8. Forest fire prevention efforts will lessen carbon sequestration, add to greenhouse warming
9. Recent news reports of sweetener reformulations raise questions about motivations
10. Work of Field Museum scientist addresses question of chance in evolution
11. Ecologists question effects of climate change on infectious diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... virus, or VSV, has long been a model system ... RNA viruses, which include viruses that cause influenza, measles ... shown that VSV has the potential to be genetically ... selectivity in killing cancer cells while sparing healthy cells, ... , For such modifications to occur, however, scientists must ...
(Date:2/9/2010)... 9 DigitalPersona, Inc., a ... continues to expand its leadership in fingerprint ...  The latest version of the popular ... featuring U.are.U® fingerprint biometrics technology from DigitalPersona, ... National Dealer Conference in Austin, TX. ...
(Date:2/8/2010)... diet may help people avoid the small areas of ... and memory, according to a study released today that ... 62nd Annual Meeting in Toronto April 10 to April ... who ate a Mediterranean-like diet were less likely to ... linked to thinking problems. , The Mediterranean diet ...
Breaking Biology News(10 mins):Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV 2Digital Dining Customers Demand Fingerprint Biometrics in Point-of-Sale Technology 2Digital Dining Customers Demand Fingerprint Biometrics in Point-of-Sale Technology 3Mediterranean diet may lower risk of brain damage that causes thinking problems 2Practice makes perfect motor memory possible for neuroprosthetic control 13109 1Practice makes perfect motor memory possible for neuroprosthetic control 13109 2Practice makes perfect motor memory possible for neuroprosthetic control 13109 3Laser technology creates new forms of metal and enhances aircraft performance 13107 1Laser technology creates new forms of metal and enhances aircraft performance 13107 2NIH funds support UAB joint replacement research 13105 1NIH funds support UAB joint replacement research 13105 2
... new insights into the mechanisms that underlie long-term memory ... , "The more we know about how long-term ... are maintained in the brain, the more we are going ... Glanzman, UCLA professor of physiological science and neurobiology, whose new ...
... available in German . , , Krakow/Halle. Major ... in fighting pathogen assault. Researchers from the Jagiellonian University ... Research (UFZ) characterized genetic variation and detected more than ... Unlike mammals, not much has been known until now ...
... published this week in Nature, the authors ... for Australian Weather and Climate Research say that ... process in controlling responses of many ecosystems particularly ... , "However, there have been significant discrepancies between real-world ...
Other Biology News:Study of marine snail leads to new insights into long-term memory 2Study of marine snail leads to new insights into long-term memory 3Study of marine snail leads to new insights into long-term memory 4New findings on immune system in amphibians 2Scientists may have solved an ecological riddle 2
(Date:2/8/2010)... China , Feb. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... modernized traditional Chinese medicine ("TCM") based in Chengdu, ... ended December 31, 2009 . , , ... $14.9 Million, Net Income Increased, ... of $0.11 on a diluted basis, ...
(Date:2/8/2010)... Mass. , Feb. 8 ... working with maternal-fetal-medicine doctors by attending the Society ... Center has been working with perinatologists and Ob/Gyn ... Torchilin , CEO of Biocell Center Corporation. "We ... on mothers and families and we are hoping ...
(Date:2/8/2010)... announced today that it has been selected by Invida Group, ... Pacific, to develop and execute its corporate communications and public ... ... (Vocus) February 8, 2010 -- LaVoie Group , a ... been selected by Invida Group , the leading provider ...
(Date:2/5/2010)... passed as fact among historians, journalists and politicians, and ... floor of the U.S. Congress: British forces used chemical ... , But that claim has never been fully squared ... historian at Colgate University. According to Douglas,s research, forthcoming ... Modern History , no such incident ever occurred. ...
Breaking Biology Technology:Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 2Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 3Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 4Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 5Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 6Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 7Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 8Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 9Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 10Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 11Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 12Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 13Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 14Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 15Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 16Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results 17Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine 2Invida Selects LaVoie Group as Public Relations Agency of Record 2Invida Selects LaVoie Group as Public Relations Agency of Record 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4
... Calif., March 25 WaferGen,Biosystems, Inc. (OTC ... gene expression, genotyping, cell biology and stem ... an exclusive distribution,agreement for the company,s SmartSlide(TM) ... United Kingdom and Labtech France in,France. The ...
... March 25, Galil Medical, a global cryotherapy company,today ... President and,Chief Executive Officer. Galil Medical is a ... treatment of cancerous and,non-cancerous tumours. Mr. Emerson is ... was most recently President and CEO of,American Medical ...
... /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a leading provider ... Meeting originally scheduled for March 25, 2008 has been,adjourned ... 2008 Annual General Meeting, the required quorum of a,majority ... with,Antigua law, the meeting is adjourned to April 8, ...
Other Biology Technology:WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France 2WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France 3WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France 4WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France 5Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer 2Sinovac Announces Adjournment of Annual General Meeting 2
... PRODUCT SPECIFICATIONS Form: White powder Assay: 1.5 - 2.0 Bleomycin ... 6.0 Loss On Drying: less than or equal to 6.0% ... A 2 : 55 - 70% B 2 : 25 ... or equal to 90% B 4 : less than or ...
... critical performance for all vacuum requirements. A ... performance to suit all applications. The large, ... of proper oil levels at a glance. ... to work with all Thermo Savant SpeedVac ...
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
Biology Products: